TP53 and cancer: For instance, clinical studies have examined using DCs transduced with wild-type, p53-expressing, replication-deficient adenovirus Ad-p53 (Ad-p53 DCs) or modified vaccinia Ankara virus p53MVA (p53MVA DCs) to treat cancer patients in combination with chemotherapy5.